Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis

Via Peters

Fabio Conforti, medical oncologist1, Laura Pala, medical oncologist1, Isabella Sala, masters student in statistics2, Chiara Oriecuia, doctoral student in statistics3, Tommaso De Pas, medical oncologist1, Claudia Specchia, professor of statistics4, Rossella Graffeo, medical oncologist5, Eleonora Pagan, postdoctoral fellow in statistics2, Paola Queirolo, medical oncologist1, Elisabetta Pennacchioli, surgical oncologist1, Marco Colleoni, […]

Patient Race Doesn’t Significantly Impact Pathological CR After Neoadjuvant Therapy for Breast Cancer

Via Peters

Although significant disparities for a subgroup of women who did not achieve a pathologic complete response (pCR) were observed, patient race did not significantly impact pCR and event-free survival (EFS) in patients with high-risk breast cancer who received targeted neoadjuvant chemotherapy, according to results presented by Beverly Kyalwazi, BS, at […]